$8.27
0.729.54%
At Close: -
$8.42
0.151.81%
After Hours: 9:29 AM EDT
15 minutes delayed
Comments
Loading...
Mesoblast
MESONASDAQ
Mesoblast (NASDAQ:MESO) Stock, Analyst Ratings, Price Targets, Forecasts
Mesoblast Ltd has a consensus price target of $6.25 based on the ratings of 6 analysts. The high is $11 issued by Piper Sandler on July 23, 2024. The low is $1.5 issued by Chardan Capital on August 4, 2023. The 3 most-recent analyst ratings were released by Piper Sandler, Cantor Fitzgerald, and Cantor Fitzgerald on July 23, 2024, September 21, 2023, and August 31, 2023, respectively. With an average price target of $15 between Piper Sandler, Cantor Fitzgerald, and Cantor Fitzgerald, there's an implied 78.15% upside for Mesoblast Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Chardan Capital
1calculated from analyst ratings
Analyst Ratings for Mesoblast
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/23/2024 | Buy Now | 30.64% | Piper Sandler | Edward Tenthoff | $4 → $11 | Upgrade | Neutral → Overweight | Get Alert |
| 06/20/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen | — | Reiterates | → Overweight | Get Alert |
| 06/04/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen | — | Reiterates | → Overweight | Get Alert |
| 09/21/2023 | Buy Now | 101.9% | Cantor Fitzgerald | Louise Chen | → $68 | Reiterates | Overweight → Overweight | Get Alert |
| 08/31/2023 | Buy Now | — | Jefferies | David Stanton | — | Upgrade | Hold → Buy | Get Alert |
| 08/31/2023 | Buy Now | 101.9% | Cantor Fitzgerald | Louise Chen | $92 → $68 | Maintains | Overweight | Get Alert |
| 08/07/2023 | Buy Now | — | Maxim Group | Jason McCarthy | — | Downgrade | Buy → Hold | Get Alert |
| 08/04/2023 | Buy Now | — | William Blair | Sami Corwin | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/04/2023 | Buy Now | -76.25% | Piper Sandler | Edward Tenthoff | $28 → $8 | Downgrade | Overweight → Neutral | Get Alert |
| 08/04/2023 | Buy Now | -82.19% | Chardan Capital | Keay Nakae | $8 → $6 | Maintains | Sell | Get Alert |
| 05/30/2023 | Buy Now | -76.25% | Chardan Capital | Keay Nakae | $10 → $8 | Maintains | Sell | Get Alert |
| 03/01/2023 | Buy Now | -70.31% | Chardan Capital | Keay Nakae | → $10 | Reiterates | → Sell | Get Alert |
| 02/01/2023 | Buy Now | 173.16% | Cantor Fitzgerald | Louise Chen | → $92 | Reiterates | → Overweight | Get Alert |
| 12/06/2022 | Buy Now | — | Jefferies | David Stanton | — | Downgrade | Buy → Hold | Get Alert |
| 09/06/2022 | Buy Now | -16.86% | Piper Sandler | Edward Tenthoff | → $28 | Initiates | → Overweight | Get Alert |
| 06/03/2022 | Buy Now | -70.31% | Chardan Capital | Keay Nakae | $26 → $10 | Maintains | Sell | Get Alert |
| 08/31/2021 | Buy Now | -22.8% | Chardan Capital | Keay Nakae | $30 → $26 | Maintains | Sell | Get Alert |
FAQ
What is the target price for Mesoblast (MESO) stock?
The latest price target for Mesoblast (NASDAQ:MESO) was reported by Piper Sandler on July 23, 2024. The analyst firm set a price target for $11.00 expecting MESO to rise to within 12 months (a possible 30.64% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mesoblast (MESO)?
The latest analyst rating for Mesoblast (NASDAQ:MESO) was provided by Piper Sandler, and Mesoblast upgraded their overweight rating.
When was the last upgrade for Mesoblast (MESO)?
The last upgrade for Mesoblast Ltd happened on July 23, 2024 when Piper Sandler raised their price target to $11. Piper Sandler previously had a neutral for Mesoblast Ltd.
When was the last downgrade for Mesoblast (MESO)?
The last downgrade for Mesoblast Ltd happened on August 7, 2023 when Maxim Group changed their price target from N/A to N/A for Mesoblast Ltd.
When is the next analyst rating going to be posted or updated for Mesoblast (MESO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mesoblast, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mesoblast was filed on July 23, 2024 so you should expect the next rating to be made available sometime around July 23, 2025.
Is the Analyst Rating Mesoblast (MESO) correct?
While ratings are subjective and will change, the latest Mesoblast (MESO) rating was a upgraded with a price target of $4.00 to $11.00. The current price Mesoblast (MESO) is trading at is $8.42, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.